Stem Cell Therapy Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Japan - Size and Forecast 2023-2027

Published: Oct 2023

Pages: 166

SKU: IRTNTR43432

Snapshot

Stem Cell Therapy Market Size 2023-2027

The global stem cell therapy market size is estimated to grow by USD 11.66 billion at a CAGR of 15.93% between 2022 and 2027. With increasing advances in science and technology, consciousness has also increased. However, the knowledge is limited to aspects such as the high cost and adverse effects of regenerative medicine and not scientific facts. The cost is only addressed in developing countries where large insurers provide incentives to employers to send patients abroad. In certain countries with universal healthcare coverage, individuals may be paid by the government to be treated in other countries. These steps improve patient accessibility, making stem cells a more feasible option. This has led to the development of stem cell tourism in which patients travel to countries that do not have strict regulatory restrictions.

What will be the size of the Stem Cell Therapy Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Segmentation by Application, Type, and Geography Analysis

Technavio has segmented the market into :

The application is classified into cancer, musculoskeletal disorder, cardiovascular disease, and others
The type is classified into allogeneic transplants and autologous transplants
The geography segment includes key regions such as North America, Europe, Asia, and the Rest of the World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.

Application Analysis

Cancer

The market share growth by the cancer segment will be significant during the forecast period. Cellular therapies are given to boost the ability of a patient's immune system to ability to fight cancer. They are made by taking a specific set of cells from the patient blood, they were altered and then administered back to the patient so that they would be more effective in attacking cancer cells.

Get a glance at the market contribution of various segments View a PDF Sample

The cancer segment was valued at USD 2.53 billion in 2017. Stem cell therapy for cancer treats blood-related diseases like non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, and leUKemia. The market is expected to grow over the forecast period, owing to the increased use of cell therapy for cancer. These factors will drive the growth of the global market during the forecast period.

Type Analysis

Allogeneic transplants

Allogeneic transplants are preferred more than autologous transplants as the scaling-up process is less complex than autologous, and they are financially viable. These transplants are preferred by patients as well as physicians and, thus, have a significant market share in the global market. Allogeneic transplantation is immunosuppressive and has the ability to repair tissues, in particular mesenchymal stem cells. Hence this transplantation elicits only a lower or weakened immune response upon implantation. Hence, they pose as a promising cell-based therapy. These factors will drive the growth of the global market during the forecast period.

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America occupies the largest share of the market. The US and Canada are the leading revenue contributors due to advanced facilities for stem cell isolation and storage. Also, efforts by the US federal authorities to regulate the US stem cell market have also increased the market growth of approved brands. Further, the increasing funds from government and private organizations will foster the development of stem cell therapies. The funding will contribute to the growth of the market in the region during the forecast period.

Buy Now Full Report and Discover More

Key Stem Cell Therapy Market Players

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Athersys Inc. - The company offers stem cell therapies such as MultiStem products.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics

Umbilical stem cell therapy offers promising avenues for treating various medical conditions, including wounds, injuries, and neurologic disorders. LifeCell, a key player in the field, facilitates access to therapy through financial assistance programs, aiding individuals with lung dysfunction and chronic disorders. Allogenic stem cell therapy, employed for conditions like musculoskeletal disorders and cardiovascular diseases, avoids invasive surgeries, harnessing the potential of mesenchymal stem cells (MSCs). These therapies are administered in hospitals and specialized cell therapy production facilities, with a focus on precision medicine and personalized treatment approaches. Clinical trials explore the efficacy of the therapy in cancer patients and individuals with chronic injuries, fostering innovation and advancing the realm of personalized medicines for chronic disorders and immune system-related ailments.

Wounds and injuries often necessitate advanced medical attention. Service companies play a vital role in providing healthcare solutions through efficient distribution channels like direct tenders or third-party distributors. Organizations like the World Health Organization monitor healthcare indices, focusing on liver, bone, and cartilage diseases, spurring R&D investments for central nervous system treatments and shaping the healthcare price index.

Key Market Drivers

The surge in chronic diseases globally is fueling the expansion of the market. Chronic conditions like heart disease, diabetes, stroke, cancer, obesity, and arthritis are increasingly prevalent, posing significant burdens on individuals and healthcare systems. A substantial portion of the global population is affected by one or more chronic ailments, with a quarter of adults enduring two or more such conditions. Chronic diseases often lead to tissue or organ damage, necessitating therapies focused on symptom management rather than cure. As a result, there's a growing adoption of cell therapies for chronic disease treatment, propelling the growth of the global market. This trend is expected to persist and drive further market expansion in the forecast period.

Significant Market Trends

The rise in costs of the transplantation is a key trend in market growth. Transplanting of stem cells is expensive as it requires high levels of specialized equipment and resources. The difference in the conditioning regimen and the type of transplant decide the cost of the transplantation. The median healthcare cost for allogeneic hematopoietic transplants was generally higher than for autologous ones.

However, the main cost factor in the case of autologous therapy arises from the fact that each individual has to undergo screening and testing, and stem cells have to be isolated and harvested in individual batches. In allogeneic transplantation, screening is done once to find suitable donors, and then a cell bank system can be created. These factors will positively impact the growth of the global market during the forecast period.

Major Market Challenges

The safety concerns from stem cell therapy are a major challenge in market growth. There are various factors that contribute to the varying degrees of side effects experienced with stem cell therapy. In some patients, the side effects may be acute, developing immediately after transplantation. In others, they may be chronic, developing after a month or 100 days.

However, transplanted tissue may be rejected by the host immune system, posing safety concerns. Aggressive induction therapy is the current methodology used to prevent acute rejection. However, it does not guarantee long-term graft survival and may also result in an increased risk of infections. These factors will hinder the growth of the global market during the forecast period.

Buy Now Full Report and Discover More

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Market Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.

Application Outlook
- Cancer
- Musculoskeletal disorder
- Cardiovascular disease
- Others

Type Outlook
- Allogeneic transplants
- Autologous transplants

Region Outlook
- North America
  - The U.S.
  - Canada
- Europe
  - The U.K.
  - Germany
  - France
  - Rest of Europe
- Asia
  - China
  - India
- ROW
  - Austrailia
  - Argentina
  - Rest of the World

Market Analyst Overview

The market is witnessing significant advancements and adoption, offering treatment options for a wide array of medical conditions. Stem cells, sourced from placental and umbilical cord blood, are utilized in therapies such as allogenic and autologous stem cell therapy. These treatments target various health issues, including musculoskeletal disorders, wounds, injuries, cardiovascular diseases, and gastrointestinal diseases. Stem cell therapy finds application in hospitals, surgical centers, and therapeutic companies, distributed through direct tenders or third-party distributors. As research and development investments surge, precision medicine, Allogenic type stem cell therapy and clinical trials expand, benefiting cancer patients and individuals with chronic disorders. However, challenges persist, including high costs, ethical concerns surrounding embryonic stem cells, and the need for technological advancements in stem cell banking and personalized medicines. Despite hurdles, the market continues to grow, driven by advancements in tissue engineering, regenerative medicine, and the emergence of innovative therapies.

Further, the field of regenerative medicine has witnessed remarkable advancements in utilizing stem cells for therapeutic purposes. Umbilical stem cells, derived from umbilical cord blood, hold immense potential in treating a wide range of conditions, including wounds, injuries, Invasive surgery, and various diseases. Allogenic stem cell therapy, involving the transplantation of cells from a donor, is increasingly employed in surgeries and medical procedures. These therapies target conditions such as cerebrovascular diseases, neurological disorders, autoimmune disorders, and spinal cord injuries. Research and development investments have fueled breakthroughs in treating conditions like Parkinson's disease, ALS, and stroke recovery. Moreover, technological advancements have facilitated the development of cell therapy production facilities, offering cost-effective solutions for patients. Private vendors, NGOs, and organizations like the National Stem Cell Foundation contribute to advancing regenerative medicine, offering hope for patients with chronic injuries and disorders.

Stem Cell Therapy Market Scope
Report Coverage	Details
Page number	166
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 15.93%
Market growth 2023-2027	USD 11.66 billion
Market structure	Fragmented
YoY growth 2022-2023(%)	15.45
Regional analysis	North America, Europe, Asia, and the Rest of the World (ROW)
Performing market contribution	North America at 41%
Key countries	US, Germany, UK, China, and Japan
Competitive landscape	Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
Key companies profiled	Athersys Inc., Becton Dickinson and Co., Brainstorm Cell Therapeutics Inc., Bristol Myers Squibb Co., CRISPR Therapeutics AG, Cynata Therapeutics Ltd., Cytori Therapeutics Inc., FUJIFILM Corp., Gamida Cell Ltd., Johnson and Johnson, Lonza Group Ltd., Mesoblast Ltd., Novartis AG, Pfizer Inc., Pluristem Therapeutics Inc., ReNeuron Group plc, STEMCELL Technologies Inc., Takeda Pharmaceutical Co. Ltd., Thermo Fisher Scientific Inc., and Vericel Corp.
Market dynamics	Parent market analysis, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our Market forecast report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
Precise estimation of the size of the market size and its contribution to the parent market
Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
Thorough market growth analysis of the market’s competitive landscape and detailed information about vendors
Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2022

3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global stem cell therapy market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on global stem cell therapy market 2017 - 2021 ($ million)

4.2 Application Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ million)

4.3 Type Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – Type Segment 2017 - 2021 ($ million)

4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

6.1 Market segments
- Exhibit 30: Chart on Application - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Application - Market share 2022-2027 (%)

6.2 Comparison by Application
- Exhibit 32: Chart on Comparison by Application
- Exhibit 33: Data Table on Comparison by Application

6.3 Cancer - Market size and forecast 2022-2027
- Exhibit 34: Chart on Cancer - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Cancer - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Cancer - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Cancer - Year-over-year growth 2022-2027 (%)

6.4 Musculoskeletal disorder - Market size and forecast 2022-2027
- Exhibit 38: Chart on Musculoskeletal disorder - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Musculoskeletal disorder - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Musculoskeletal disorder - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Musculoskeletal disorder - Year-over-year growth 2022-2027 (%)

6.5 Cardiovascular disease - Market size and forecast 2022-2027
- Exhibit 42: Chart on Cardiovascular disease - Market size and forecast 2022-2027 ($ million)
- Exhibit 43: Data Table on Cardiovascular disease - Market size and forecast 2022-2027 ($ million)
- Exhibit 44: Chart on Cardiovascular disease - Year-over-year growth 2022-2027 (%)
- Exhibit 45: Data Table on Cardiovascular disease - Year-over-year growth 2022-2027 (%)

6.6 Others - Market size and forecast 2022-2027
- Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
- Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
- Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
- Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)

6.7 Market opportunity by Application
- Exhibit 50: Market opportunity by Application ($ million)
- Exhibit 51: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Type

7.1 Market segments
- Exhibit 52: Chart on Type - Market share 2022-2027 (%)
- Exhibit 53: Data Table on Type - Market share 2022-2027 (%)

7.2 Comparison by Type
- Exhibit 54: Chart on Comparison by Type
- Exhibit 55: Data Table on Comparison by Type

7.3 Allogeneic transplants - Market size and forecast 2022-2027
- Exhibit 56: Chart on Allogeneic transplants - Market size and forecast 2022-2027 ($ million)
- Exhibit 57: Data Table on Allogeneic transplants - Market size and forecast 2022-2027 ($ million)
- Exhibit 58: Chart on Allogeneic transplants - Year-over-year growth 2022-2027 (%)
- Exhibit 59: Data Table on Allogeneic transplants - Year-over-year growth 2022-2027 (%)

7.4 Autologous transplants - Market size and forecast 2022-2027
- Exhibit 60: Chart on Autologous transplants - Market size and forecast 2022-2027 ($ million)
- Exhibit 61: Data Table on Autologous transplants - Market size and forecast 2022-2027 ($ million)
- Exhibit 62: Chart on Autologous transplants - Year-over-year growth 2022-2027 (%)
- Exhibit 63: Data Table on Autologous transplants - Year-over-year growth 2022-2027 (%)

7.5 Market opportunity by Type
- Exhibit 64: Market opportunity by Type ($ million)
- Exhibit 65: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 67: Chart on Market share by geography 2022-2027 (%)
- Exhibit 68: Data Table on Market share by geography 2022-2027 (%)

9.2 Geographic comparison
- Exhibit 69: Chart on Geographic comparison
- Exhibit 70: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2022-2027
- Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)

9.4 Europe - Market size and forecast 2022-2027
- Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)

9.5 Asia - Market size and forecast 2022-2027
- Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)

9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

9.7 US - Market size and forecast 2022-2027
- Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)

9.8 Germany - Market size and forecast 2022-2027
- Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)

9.9 UK - Market size and forecast 2022-2027
- Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)

9.10 China - Market size and forecast 2022-2027
- Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)

9.11 Japan - Market size and forecast 2022-2027
- Exhibit 103: Chart on Japan - Market size and forecast 2022-2027 ($ million)
- Exhibit 104: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
- Exhibit 105: Chart on Japan - Year-over-year growth 2022-2027 (%)
- Exhibit 106: Data Table on Japan - Year-over-year growth 2022-2027 (%)

9.12 Market opportunity by geography
- Exhibit 107: Market opportunity by geography ($ million)
- Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 109: Impact of drivers and challenges in 2022 and 2027

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 110: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 111: Overview on factors of disruption

11.4 Industry risks
- Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 113: Vendors covered

12.2 Market positioning of vendors
- Exhibit 114: Matrix on vendor position and classification

12.3 Athersys Inc.
- Exhibit 115: Athersys Inc. - Overview
- Exhibit 116: Athersys Inc. - Product / Service
- Exhibit 117: Athersys Inc. - Key offerings

12.4 Bristol Myers Squibb Co.
- Exhibit 118: Bristol Myers Squibb Co. - Overview
- Exhibit 119: Bristol Myers Squibb Co. - Product / Service
- Exhibit 120: Bristol Myers Squibb Co. - Key news
- Exhibit 121: Bristol Myers Squibb Co. - Key offerings

12.5 CRISPR Therapeutics AG
- Exhibit 122: CRISPR Therapeutics AG - Overview
- Exhibit 123: CRISPR Therapeutics AG - Product / Service
- Exhibit 124: CRISPR Therapeutics AG - Key offerings

12.6 Cynata Therapeutics Ltd.
- Exhibit 125: Cynata Therapeutics Ltd. - Overview
- Exhibit 126: Cynata Therapeutics Ltd. - Product / Service
- Exhibit 127: Cynata Therapeutics Ltd. - Key offerings

12.7 FUJIFILM Corp.
- Exhibit 128: FUJIFILM Corp. - Overview
- Exhibit 129: FUJIFILM Corp. - Business segments
- Exhibit 130: FUJIFILM Corp. - Key news
- Exhibit 131: FUJIFILM Corp. - Key offerings
- Exhibit 132: FUJIFILM Corp. - Segment focus

12.8 Gamida Cell Ltd.
- Exhibit 133: Gamida Cell Ltd. - Overview
- Exhibit 134: Gamida Cell Ltd. - Product / Service
- Exhibit 135: Gamida Cell Ltd. - Key offerings

12.9 Johnson and Johnson
- Exhibit 136: Johnson and Johnson - Overview
- Exhibit 137: Johnson and Johnson - Business segments
- Exhibit 138: Johnson and Johnson - Key news
- Exhibit 139: Johnson and Johnson - Key offerings
- Exhibit 140: Johnson and Johnson - Segment focus

12.10 Lonza Group Ltd.
- Exhibit 141: Lonza Group Ltd. - Overview
- Exhibit 142: Lonza Group Ltd. - Business segments
- Exhibit 143: Lonza Group Ltd. - Key news
- Exhibit 144: Lonza Group Ltd. - Key offerings
- Exhibit 145: Lonza Group Ltd. - Segment focus

12.11 Mesoblast Ltd.
- Exhibit 146: Mesoblast Ltd. - Overview
- Exhibit 147: Mesoblast Ltd. - Product / Service
- Exhibit 148: Mesoblast Ltd. - Key offerings

12.12 Novartis AG
- Exhibit 149: Novartis AG - Overview
- Exhibit 150: Novartis AG - Business segments
- Exhibit 151: Novartis AG - Key offerings
- Exhibit 152: Novartis AG - Segment focus

12.13 Pfizer Inc.
- Exhibit 153: Pfizer Inc. - Overview
- Exhibit 154: Pfizer Inc. - Product / Service
- Exhibit 155: Pfizer Inc. - Key news
- Exhibit 156: Pfizer Inc. - Key offerings

12.14 Pluristem Therapeutics Inc.
- Exhibit 157: Pluristem Therapeutics Inc. - Overview
- Exhibit 158: Pluristem Therapeutics Inc. - Product / Service
- Exhibit 159: Pluristem Therapeutics Inc. - Key offerings

12.15 ReNeuron Group plc
- Exhibit 160: ReNeuron Group plc - Overview
- Exhibit 161: ReNeuron Group plc - Product / Service
- Exhibit 162: ReNeuron Group plc - Key offerings

12.16 Takeda Pharmaceutical Co. Ltd.
- Exhibit 163: Takeda Pharmaceutical Co. Ltd. - Overview
- Exhibit 164: Takeda Pharmaceutical Co. Ltd. - Product / Service
- Exhibit 165: Takeda Pharmaceutical Co. Ltd. - Key news
- Exhibit 166: Takeda Pharmaceutical Co. Ltd. - Key offerings

12.17 Vericel Corp.
- Exhibit 167: Vericel Corp. - Overview
- Exhibit 168: Vericel Corp. - Product / Service
- Exhibit 169: Vericel Corp. - Key news
- Exhibit 170: Vericel Corp. - Key offerings

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 171: Inclusions checklist
- Exhibit 172: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 173: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 174: Research methodology
- Exhibit 175: Validation techniques employed for market sizing
- Exhibit 176: Information sources

13.5 List of abbreviations
- Exhibit 177: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

stem cell therapy market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis